Lyphochek Immunoassay Plus Control
Multi-Analyte Controls, All Kinds (Assayed). 510(k) K981532, from Bio-Rad (Irvine, CA). Product code JJY, class 1.
As of Nov 19, 2026, K981532 is an FDA 510(k) held by Bio-Rad, substantially equivalent on May 12, 1998 after 13 days, with no recalls tied to it in FDA's recall database.
- Review time: 13 days
- Recalls: 0
- Cited as a predicate by: 7 devices
Lyphochek Immunoassay Plus Control is intended for use as an assayed quality control serum to monitor the precision of laboratory testing procedures for the analytes listed in this package insert.
- Lyphochek(R) Immunoassay Contr Serum (Human) 1,2,3K891475 · Bio-Rad · Aug 1, 1989
- Vitros Immunodiagnostic Products Anemia ControlsK990016 · Ortho-Clinical Diagnostics, Inc. · May 19, 1999
- Lyphochek Maternal Serum Control, Model 220K984594 · Bio-Rad · Feb 2, 1999
- Randox Immunoassay Speciality Control (Ii), Level 1, Level 2 and Level 3K121603 · Randox Laboratories, Ltd. · Nov 20, 2012
- Pairetex Optimized Composite Mesh (Pco-Fx Refrences)K110663 · Sofradim Production · Aug 11, 2011
- Thermo Scientific Mas Omni-Immune, Mas Omni Immune ProK110616 · Microgenics Corp. · Jun 29, 2011
- Quest Diagnostics Immunoassay/Tdm ControlK050536 · Bio-Rad · Mar 24, 2005
- Liquichek Specialty Immunoassay ControlK043108 · Bio-Rad Laboratories, Inc. · Dec 7, 2004
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 29, 1998
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1660
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files